UNSPSC 51343310: Memotine hydrochloride

This classification denotes an antiviral agent with the molecular formula C17H17NO2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZP0HNU59MM, chemically known as isoquinoline, 3,4-dihydro-1-(4-methoxyphenoxy)methyl]-, hydrochloride but more generally known as memotine hydrochloride, which bears US NIH Compound Identifier 25350. Most nations, for tariff and trade purposes, schedule memotine hydrochloride under HS 29334990 and SITC 51575. As of Q4 2014, MEMOTINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity.

Memotine hydrochloride bears US NLM identifiers UMLS ID C2981325 and NCI Concept Code C87665. SMILES: COC1CCC(CC1)OCC2=NCCC3C2CCCC3.CL.

UNSPSC 51343310 Memotine hydrochloride, a Commodity code, does not align with the recent state and local procurement activity tagged under it. The code nominally describes a specific pharmaceutical compound, but the four most recent opportunities posted under this code solicit naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, generic multi-source pharmaceuticals and OTC products, and emergency medical and first aid supplies—none of which are memotine hydrochloride. This mismatch suggests either a classification error in the source data or a substantial drift between the code's intended scope and how issuing bodies are applying it in practice. The code shows little relevant recent activity for the specific product it nominates.

The issuing bodies pursuing opportunities tagged under this code include a county health department (Seminole County, Florida), a state health and human services agency (Texas HHS Commission), a city fire department (City of Tampa), and a multistate cooperative purchasing alliance (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP, with participation from Minnesota and Oregon). The geographic spread spans Florida, Texas, and the Upper Midwest. Representative recent solicitations include Seminole County's IFB for naloxone and drug deactivation systems (response deadline July 26, 2023), the City of Tampa's IFB for medical and first aid supplies for the fire department with an estimated contract value of $700,000 (due March 13, 2026), and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026. Given the code's stated focus on memotine hydrochloride specifically and the absence of that product in recent opportunities, this code warrants careful verification before pursuit.